Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...
Rare diseases have become an attractive target for pharmaceutical companies both in Australia and internationally with ...
GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...
Analysis by Mount Sinai researcher from First-of-its kind global trial could lead to future therapies to prevent deadly ...
MyChesCo on MSN3d
Palvella Therapeutics Expands Phase 3 Trial to Younger PatientsWAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the expansion of SELVA, its Phase 3 clinical trial of ...
Rallybio Corporation , a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced that the first ...
Two leading US-based autism centres have joined BlinkLab’s autism diagnostic registrational trial with the paediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback